| CAS ID: | 471-53-4 |
| Molecular Formula: | C30H46O4 |
| Molecular Weight: | 470.7 g/mol |
| Monoisotopic Mass: | 470.3396 g/mol |
| Class: | Small Molecule |
| Natural Product: | Yes |
| Other Names: | NSC-35350 | ENOXOLONE | GLYCYRRHETIC ACID | NSC-35347 | RHETINIC ACID | URALENIC ACID |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1 | See All |
| InChI Key: | MPDGHEJMBKOTSU-YKLVYJNSSA-N | |
| Smiles: | CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(=O)O | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 29552620 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Intestinal fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 23341968 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Nrf2 | ||
| PubChem: | 10114 |
| ChEMBL: | CHEMBL230006 |